Population
583 ADNI participants with baseline florbetapir positron emission tomography amyloid imaging and…
Design
Cross-sectional
Authors
Loading...
May indicate false-positive MCI diagnoses from amyloid heterogeneity; leaves open validation of subtype-specific criteria in prospective studies.
Considerable heterogeneity exists in amyloid-beta levels across empirically-derived MCI subtypes, suggesting conventional MCI criteria may be susceptible to false positive diagnostic errors.
Bangen et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: